mTOR and metabolic pathways in T cell quiescence and functional activation.
about
Balancing Inflammation: The Link between Th17 and Regulatory T CellsModulation of T Cell Metabolism and Function through Calcium SignalingMetabolic regulation of regulatory T cell development and functionStaphylococcus aureus alpha-toxin mediates general and cell type-specific changes in metabolite concentrations of immortalized human airway epithelial cells.Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiencymTOR signaling, Tregs and immune modulation.mTOR Links Environmental Signals to T Cell Fate Decisions.Metabolic Control of Th17 Cell Generation and CNS InflammationT cell receptor-dependent activation of mTOR signaling in T cells is mediated by Carma1 and MALT1, but not Bcl10.G0S2 modulates homeostatic proliferation of naïve CD8⁺ T cells and inhibits oxidative phosphorylation in mitochondriaPreventing Allograft Rejection by Targeting Immune Metabolism.Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation.Normalization of CD4+ T cell metabolism reverses lupusMetabolic Regulation of Natural Killer Cell IFN-γ Production.Impact of Metabolism on T-Cell Differentiation and Function and Cross Talk with Tumor Microenvironment.Immunometabolic Regulation of Interleukin-17-Producing T Helper Cells: Uncoupling New Targets for Autoimmunity.Amino-acid transporters in T-cell activation and differentiation.Autophagy: a new target or an old strategy for the treatment of Crohn's disease?Nutrient sensing and metabolic stress pathways in innate immunity.Transcriptional regulation of the stress response by mTOR.Metabolic mysteries of the inflammatory response: T cell polarization and plasticity.Immune activation and induction of memory: lessons learned from controlled human malaria infection with Plasmodium falciparum.Role of the reprogramming factor KLF4 in blood formation.Co-inhibitory blockade while preserving tolerance: checkpoint inhibitors for glioblastoma.Pathogenic Role of IL-17-Producing Immune Cells in Obesity, and Related Inflammatory Diseases.Mammalian target of rapamycin complex 2 modulates αβTCR processing and surface expression during thymocyte development.Tuning mTOR activity for immune balance.Metabolic Reprogramming Mediated by the mTORC2-IRF4 Signaling Axis Is Essential for Macrophage Alternative Activation.Obese donor mice splenocytes aggravated the pathogenesis of acute graft-versus-host disease via regulating differentiation of Tregs and CD4+ T cell induced-type I inflammation.Adoptive transfer of murine T cells expressing a chimeric-PD1-Dap10 receptor as an immunotherapy for lymphoma.Investigating Cellular Quiescence of T Lymphocytes and Antigen-Induced Exit from Quiescence.Insulin and Insulin-like growth factor-1 can activate the phosphoinositide-3-kinase /Akt/FoxO1 pathway in T cells in vitro.Metabolic Adaptations of CD4+ T Cells in Inflammatory Disease.Metformin inhibits proliferation and cytotoxicity and induces apoptosis via AMPK pathway in CD19-chimeric antigen receptor-modified T cells.The CBM-opathies-A Rapidly Expanding Spectrum of Human Inborn Errors of Immunity Caused by Mutations in the CARD11-BCL10-MALT1 ComplexRole of mTOR Signaling in Tumor Microenvironment: An OverviewThe tumor suppressor menin prevents effector CD8 T-cell dysfunction by targeting mTORC1-dependent metabolic activation
P2860
Q26740440-528455C6-E8EA-4E71-A214-96EA4ADFFB76Q26821801-C5894EAE-70DD-4083-9B78-25518D4DB492Q26852681-91D91579-7A42-4D4D-8775-C6565170CB58Q30440120-18CBA40B-B432-47D7-95E9-4623C1A81D58Q34380652-7B35C599-212F-49DC-A76A-7C685357446EQ34919712-B5A58C38-F752-4678-91E9-3067E7D22BEBQ34986648-E930F182-D68D-4ED0-B422-B5082578A3A8Q35101158-A4E68EEE-DD2C-4044-B719-9B170E2FD2E3Q35510049-32D159C5-3A2A-4DB4-A728-D31D88997E90Q35935293-A2E2EB1F-C6AE-4C20-A596-90105D7CED68Q36225691-8B0452ED-00A6-426A-83B2-64272774CC4AQ37397572-8BCBBB4A-5DE1-4215-8A6B-A8D0181A7C14Q37625717-8ED3961C-E91E-46C8-AA4A-0C8485F3D823Q37679330-1C5185C8-5793-4A83-99AE-80AEAA53F06EQ37694431-8D1E993C-D812-48F8-83B0-D841B710C501Q37712496-857B750D-1F23-4DB1-AC36-0209EB60CA5FQ37745334-7F2E68FC-CC5C-4599-88AF-8FFADF0AA1E8Q38099513-6CFE5A82-E9A7-4A29-8EEE-D91C98CC6F7FQ38120042-79859B27-3319-43BE-98E1-0333BB3129E5Q38225367-B68FC2C2-FBBF-4AB9-ADF9-51E60152B21FQ38268249-62D0A5F2-5132-48DE-9652-7560CC728C9FQ38728601-64EB7225-317D-4E40-8414-3AF0B9804C21Q38747777-24AF4F89-3595-43BB-9E93-8179E200F854Q39160992-D70EE7CC-840B-4111-9696-E3BF395E0498Q39434888-2C656333-477C-4E5C-BD7D-6FBE45EF1A9AQ41873879-091CAA8E-7D77-475A-ABAB-9B0EC7B07AADQ42156145-6B55C783-C388-43D6-8FDB-B2B6AB9A64ADQ42339950-77B849B3-E23E-44E6-9722-17512AD4B3ACQ47157951-EC4D4FFD-2680-4925-AA0B-326B4A3DBB2EQ48188242-F509FA72-53CA-4F04-98BC-DC694EAA831DQ50067591-13720678-8982-4CC3-8C21-B36A24B8986EQ54124254-1B4E6D52-9103-4F86-B21F-A355A5D9778CQ54985437-AE5036B2-D018-4A5C-85A0-65175A0495D7Q55089089-D5BD2E48-5014-4231-9A14-426CFCF7E715Q57072726-28F3175B-10EA-4588-B728-4650442C7C2CQ58766017-6F168F43-9080-4899-8383-A8024E3F4AE6Q58771187-17B89EA8-4E2B-456A-9B7A-82A154AEA8E5
P2860
mTOR and metabolic pathways in T cell quiescence and functional activation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
mTOR and metabolic pathways in T cell quiescence and functional activation.
@en
mTOR and metabolic pathways in T cell quiescence and functional activation.
@nl
type
label
mTOR and metabolic pathways in T cell quiescence and functional activation.
@en
mTOR and metabolic pathways in T cell quiescence and functional activation.
@nl
prefLabel
mTOR and metabolic pathways in T cell quiescence and functional activation.
@en
mTOR and metabolic pathways in T cell quiescence and functional activation.
@nl
P2860
P1476
mTOR and metabolic pathways in T cell quiescence and functional activation.
@en
P2093
P2860
P304
P356
10.1016/J.SMIM.2012.12.004
P577
2012-12-01T00:00:00Z